Researchers developed a liquid biopsy method that improved detection of live circulating tumor cells in triple negative ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...

Researchers at University of California San Diego have identified a previously unrecognized treatment target for ...

Pitavastatin, a cholesterol lowering drug, slashes chemotherapy resistance in breast cancer by obstructing a specific protein ...

Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.

Triple Negative Breast Cancer (TNBC) is one of the most aggresive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

At Thomas’s first oncology appointment, her doctor told her to prepare for the worst. “[It] was absolutely soul crushing,” says Thomas. She immediately searched for other women with triple-negative ...

Laura Huppert, MD, discusses efficacy and safety outcomes from the phase 3 ASCENT-04 trial, which compared the combination of ...

Beyond the Gates is doing important work in raising awareness about breast cancer through a storyline that will resonate with ...